Biomarkers of diabetes

A molecular biomarker is a gene, molecule, or natural trait that helps recognize disease. In diabetes, HbA1c is considered a biomarker to identify risk factors for retinopathy, vascular disease and nephropathy. These provide preventative measures during the subclinical phase. The proper use of the biomarker in the growth of anti-diabetic drugs can help in a quick and better understanding of the pathological process of diabetes.


    Related Conference of Biomarkers of diabetes

    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 09-10, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK

    Biomarkers of diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in